Cepheid (NASDAQ:CPHD)

CAPS Rating: 3 out of 5

A molecular diagnostics company that develops, manufactures, and markets fully-integrated systems for genetic analysis in the Clinical Molecular Diagnostic, Industrial and Biothreat markets.

Recs

0
Player Avatar oneluckyguy (< 20) Submitted: 1/18/2008 4:14:40 PM : Outperform Start Price: $28.92 CPHD Score: +24.80

The future is here now.

Featured Broker Partners


Advertisement